Immunology News and Research

Latest Immunology News and Research

Sanofi Pasteur begins selling Gardasil in six E.U. countries

Sanofi Pasteur, a joint company of Merck and Sanofi-Aventis, recently began selling Merck's human papillomavirus vaccine Gardasil in Austria, Finland, Germany, Ireland, Sweden and the United Kingdom, Reuters reports (Reuters, 10/17).

19 Oct 2006

Why organs fail following massive trauma

Massive trauma, say from a sabertooth tiger attack, meant immediate death for the primitive human.

17 Oct 2006

Researchers identifiy how immune system contributes to nerve fiber damage caused by multiple sclerosis

Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.

16 Oct 2006

Heme oxygenase-1 protects against lung damage in silicosis

Levels of heme oxygenase-1 (HO-1), an antioxidant that protects against reactive oxygen species (damaging oxygen molecules that cause direct tissue injury), become elevated in the lungs of chronic silicosis patients and could represent a new treatment approach for the disease.

16 Oct 2006

Updates on pandemic flu vaccine trials to be presented at 44th Annual IDSA meeting

Preliminary results from clinical trials testing two different pandemic flu vaccine approaches - one a prime-boost strategy using different subtypes of H5N1 vaccines, the other an H5N1 vaccine delivered into the skin (intradermal) rather than the muscle - will be presented at the 44th Annual Meeting of the Infectious Diseases Society of America.

16 Oct 2006

New target for cancer therapy identified by Australian researchers

A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.

21 Sep 2006

Study reveals white blood cells can both hurt and help transplanted kidneys

In an example of biological irony, the same white blood cell chemistry known to damage kidneys used for transplants may also help prevent such damage, according to a federally funded study in genetically engineered mice at Johns Hopkins.

21 Sep 2006

M. D. Anderson targets asthma and allergic diseases

A new research alliance focuses on a molecular master switch suspected of igniting the inflammatory immune response that drives asthma and other allergic diseases.

20 Sep 2006

Live H5N1 avian flu vaccines show promise

When tested in mice and ferrets, experimental vaccines based on live, weakened versions of different strains of the H5N1 avian influenza virus were well-tolerated and protected the animals from a deadly infection with naturally occurring H5N1 flu viruses.

13 Sep 2006

Nitric oxide in blood and side-effects of painkillers

Cardiff University researchers have increased the understanding of why some painkillers increase the risk of heart attack and stroke.

12 Sep 2006

Live H5N1 avian flu virus vaccines show protection in animal studies

12 Sep 2006

Messy nappies may be sign of severe intestinal infection

Anyone who's ever cared for an infant or young child knows what it's like to change the occasional smelly, messy diaper.

5 Sep 2006

Permanent renal parenchymal defects after febrile UTI are closely associated with vesicoureteric reflux

This study from Italy investigated the association of vesicoureteral reflux (VUR) and renal scarring.

5 Sep 2006

Researchers decode the instructions that tell cells how to become blood

Blood cells have limited lifespans, which means that they must be continually replaced by calling up reserves, and turning these into the blood cell types needed by the body.

4 Sep 2006

Lyme disease vaccine could be on the cards

Lyme disease is the most common tick-borne disease in the Northern Hemisphere, and the most common tick-borne illness in the United States and Europe.

24 Aug 2006

Racial differences in hepatitis C viral responses

African American patients with hepatitis C (HCV) infections experience a lower response rate to the peginterferon alfa-2a and ribavirin combination treatment than Caucasian Americans, according to a study published in the August issue of Gastroenterology.

16 Aug 2006